19th January 2023
The Emerging Role of HRD Testing and the Progress of PARP Inhibitors in Ovarian Cancer
In this EMJ podcast episode, David O’Malley, Director of Gynecologic Oncology, Ohio State University, and the James Comprehensive Cancer Center, Columbus, Ohio, USA, and Christina Fotopoulou, Consultant Gynaecological Oncologist…
16th January 2023
The Latest Advancements in Ovarian Cancer Care Featured at ESMO 2022
In this episode of the EMJ Podcast, Brigitte Scott hosts Gilles Freyer, Medical Oncologist, Lyon University Hospital, France; and Domenica Lorusso, Associate Professor of Obstetrics and Gynecology, Catholic University of Rome, Italy…
9th December 2022
The Importance of Ultrasound in Rheumatology
This Podcast, hosted by Brigitte Scott, explores the important role ultrasound has in Rheumatology. Join experts Lene Terslev, Chief Consultant in Rheumatology at Rigshospitalet, and Professor of Rheumatology at Copenhagen University, Denmark, and Esperanza Naredo, Rheumatologist and Associate Professor at Universidad Autónoma de Madrid, Spain…
10th November 2022
Haematopoietic Stem Cell Transplant (HSCT) in Diffuse Cutaneous Systemic Sclerosis (dcSSc) and Potential Role of FCR001, an Investigational Allogeneic Cell Therapy
This podcast explores hematopoietic stem cell transplant in diffuse cutaneous systemic sclerosis (dcSSc) and the potential role of FCR001, an investigational allogeneic cell therapy. We are pleased to be joined by leading scleroderma expert Dinesh Khanna MD, MSc.
25th October 2022
Expert Insights into Paediatric Tuberculosis
The first podcast in this three-part series introduces the topic of paediatric tuberculosis (TB) and the concept of latent TB infection (L TBI). Statistics on the risk of progression from LTBI to active TB, as well as the risk of severe TB disease, dissemination, and death in children versus adults are shared.
19th October 2022
An Evaluation of the Value and Future Development of Multidisciplinary Teams
This specialist roundtable discussion examines the key performance indicators for an MDT and the value of the MDT to patients and team members, and focuses on barriers to change in the MDT approach, emerging therapies that could impact the MDT approach, and the evolution of collaboration between clinical and molecular MDTs.
29th July 2022
Unpacking the Immune System
This week, Peter Arkwright, Senior Lecturer in Paediatric Allergy and Immunology, Lydia Becker Institute of Immunology and Inflammation, University of Manchester, UK, joins Evgenia to speak about the prevalence of allergy and the challenges surrounding immune disease in children.
14th July 2022
Recommendations For Better Patient Outcomes in LDL-C Management
This EMJ podcast explores the vital topic of low-density lipoprotein cholesterol (LDL-C) management in relation to the treatment and prevention of atherosclerotic cardiovascular disease. Our host, George Cooper, is joined by Michal Vrablík.
14th April 2022
IVDR – the new European In-Vitro Diagnostics market regulations and its implications for the microbiology laboratories
We discuss the differences between the IVDD and IVDR regulations in Europe, the differences and similarities between different countries.
14th April 2022
New antibiotics, its implementation and adoption and the role they play in assuring more effective health treatments
We discuss the process of developing new drugs, the barriers to adoption of new available medicines by healthcare providers and practitioners.
14th April 2022
Microbiology Testing and Its Role in Combating Antimicrobial Resistance and in Assuring the Best Patient Outcomes
This podcast explores the vital role that microbiology testing will play in countering the impending challenge that antimicrobial resistance presents.
25th January 2022
UEG Week Virtual 2021 Janssen-Sponsored Virtual Satellite Symposium: “Targeting IL-12/23 in ulcerative colitis: from evidence to bedside”
This podcast reviews the Janssen-Sponsored Virtual Satellite Symposium titled “Targeting IL-12/23 in ulcerative colitis: from evidence to bedside”…